Liquid Biopsy for Cancer: Circulating Tumor Cells, Circulating Free DNA or Exosomes?

被引：182
|
作者：
Zhang, Wei [1 ,2 ]
Xia, Wenjie [1 ,3 ]
Lv, Zhengye [3 ]
Xin, Yin [3 ]
Ni, Chao [1 ,3 ]
Yang, Liu [1 ]
机构：
[1] Hangzhou Med Coll, Peoples Hosp, Zhejiang Prov Peoples Hosp, Key Lab Tumor Mol Diag & Individual Med Zhejiang, Hangzhou, Zhejiang, Peoples R China
[2] Hangzhou Med Coll, Peoples Hosp, Zhejiang Prov Peoples Hosp, Dept Endocrinol, Hangzhou, Zhejiang, Peoples R China
[3] Hangzhou Med Coll, Peoples Hosp, Zhejiang Prov Peoples Hosp, Dept Gen Surg, Hangzhou, Zhejiang, Peoples R China
来源：
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY | 2017年 / 41卷 / 02期
关键词：
Liquid biopsy; Circulating tumor cells; Circulating free DNA; Exosomes; METASTATIC BREAST-CANCER; RADIATION-INDUCED CANCER; K-RAS MUTATIONS; LUNG-CANCER; COLORECTAL-CANCER; PANCREATIC-CANCER; PROGNOSTIC VALUE; PLASMA DNA; PROSTATE-CANCER; EARLY-DIAGNOSIS;
D O I：
10.1159/000458736
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
Precision medicine and personalized medicine are based on the development of biomarkers, and liquid biopsy has been reported to be able to detect biomarkers that carry information on tumor development and progression. Compared with traditional `solid biopsy', which cannot always be performed to determine tumor dynamics, liquid biopsy has notable advantages in that it is a noninvasive modality that can provide diagnostic and prognostic information prior to treatment, during treatment and during progression. In this review, we describe the source, characteristics, technology for detection and current situation of circulating tumor cells, circulating free DNA and exosomes used for diagnosis, recurrence monitoring, prognosis assessment and medication planning. (C) 2017 The Author(s) Published by S. Karger AG, Basel
引用
收藏
页码：755 / 768
页数：14
相关论文
共 50 条
  • [21] Circulating tumor cells as liquid biopsy in larynx cancer
    Devecioglu, B.
    Guler, O. Ozensoy
    Carhan, A.
    Taspinar, R.
    Terzi, E.
    Dilck, Y.
    Calisir, E.
    Tiryaki, M.
    Pinarli, F.
    Bayir, O.
    Saylam, G.
    Korkmaz, H.
    Simsek, E.
    FEBS JOURNAL, 2016, 283 : 302 - 302
  • [22] Real-time liquid biopsy: circulating tumor cells versus circulating tumor DNA
    Alix-Panabieres, Catherine
    Pantel, Klaus
    ANNALS OF TRANSLATIONAL MEDICINE, 2013, 1 (02)
  • [23] Analysis of colorectal cancer-related mutations by liquid biopsy: Utility of circulating cell-free DNA and circulating tumor cells
    Takeda, Kohki
    Yamada, Takeshi
    Takahashi, Goro
    Iwai, Takuma
    Ueda, Koji
    Kuriyama, Sho
    Koizumi, Michihiro
    Matsuda, Akihisa
    Shinji, Seiichi
    Ohta, Ryo
    Yokoyama, Yasuyuki
    Hotta, Masahiro
    Hara, Keisuke
    Yoshida, Hiroshi
    CANCER SCIENCE, 2019, 110 (11) : 3497 - 3509
  • [24] Circulating tumor cells and the liquid biopsy
    Shaffer C.
    Genetic Engineering and Biotechnology News, 2019, 39 (03): : 42 - 44and47
  • [25] Circulating Tumor Cells : Liquid Biopsy
    Alix-Panabieres, Catherine
    Pierga, Jean-Yves
    BULLETIN DU CANCER, 2014, 101 (01) : 17 - 23
  • [26] Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer
    Cheng, Feifei
    Su, Li
    Qian, Cheng
    ONCOTARGET, 2016, 7 (30) : 48832 - 48841
  • [27] Circulating tumor DNA as a 'liquid biopsy' in head and neck cancer
    Perdomo, Sandra
    Anantharaman, Devasena
    Mckay, James
    Brennan, Paul
    CANCER RESEARCH, 2015, 75
  • [28] Circulating Tumor DNA Testing-Liquid Biopsy of a Cancer
    Shohdy, Kyrillus S.
    West, Howard
    JAMA ONCOLOGY, 2020, 6 (05) : 792 - 792
  • [29] Circulating miRNA and circulating tumor DNA application as liquid biopsy markers in gastric cancer
    Shaker, Farhad
    Razi, Sepideh
    Rezaei, Nima
    CLINICAL BIOCHEMISTRY, 2024, 129
  • [30] Circulating free DNA: a 'liquid biopsy' for the early detection of cancer?
    Trigg, R. M.
    Giblett, S. M.
    Pritchard, C. A.
    Shaw, J. A.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S238 - S238
12345